Plattenepithelkarzinom:
R2810-ONC-1788: A Randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab Versus Placebo after Surgery and Radiation Therapy in Patients with High Risk Cutaneous Squamous Cell Carcinoma
- Status: Rekrutierung geschlossen
- zur Studienbeschreibung